Glaxo Says Its Covid-19 Antibody Drug Works Against Omicron

GlaxoSmithKline and Vir said their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies, even as early data suggests that similar treatments work less well against the strain.